Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/cmdc.201000395. Scheme 1. a) HCl, MeOH; b) Et 3 N, 4-CO 2 MePhSO 2 Cl, CH 2 Cl 2 ; c) DEAD, Ph 3 P, iso-amyl alcohol, THF; d) LiBH 4 , THF; e) TBDPS-Cl, imidazole, CH 2 Cl 2 ; f) H 2 , Pd(OH) 2 , MeOH; g)
Epsilon substituted lysinol derivatives as HIV-1 protease inhibitors
β Scribed by Kristen L.G. Jones; M. Katharine Holloway; Hua-Poo Su; Steven S. Carroll; Christine Burlein; Sinoeun Touch; Daniel J. DiStefano; Rosa I. Sanchez; Theresa M. Williams; Joseph P. Vacca; Craig A. Coburn
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 714 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
β¦ Synopsis
A series of HIV-1 protease inhibitors containing an epsilon substituted lysinol backbone was synthesized. Two novel synthetic routes using N-boc-L-glutamic acid alpha-benzyl ester and 2,6-diaminopimelic acid were developed. Incorporation of this epsilon substituent enabled access to the S2 pocket of the enzyme, affording high potency inhibitors. Modeling studies and synthetic efforts suggest the potency increase is due to both conformational bias and van der Waals interactions with the S2 pocket.
π SIMILAR VOLUMES
Using a blockwise approach, N-substituted oligoglycine (NSGs) peptoids bearing Nac.etylglucosamine residues in different position of the side chain were efficiently synthesized by a reiterative strategy involving mono N-alkylation and bromoacetylation.